4.6 Article

Cisplatin and oleanolic acid Co-loaded pH-sensitive CaCO3 nanoparticles for synergistic chemotherapy

Related references

Note: Only part of the references are listed.
Article Engineering, Biomedical

Mitochondrial Ca2+-overloading by oxygen/glutathione depletion-boosted photodynamic therapy based on a CaCO3 nanoplatform for tumor synergistic therapy

Jiawei Zhu et al.

Summary: A CaCO3-based nano-platform responsive to the tumor microenvironment was designed. The released CAT and BSO relieved tumor hypoxia, enhanced PDT efficacy, and induced cell apoptosis, while also destroying the Ca2+ buffering capacity leading to mitochondrial Ca2+ overloading. The synergistic effect of enhanced PDT and mitochondrial Ca2+ overloading showed remarkable antitumor performance.

ACTA BIOMATERIALIA (2022)

Review Medicine, Research & Experimental

Anticancer activity of oleanolic acid and its derivatives: Recent advances in evidence, target profiling and mechanisms of action

Zhong-Yuan Tang et al.

Summary: Oleanolic acid (OA) and its derivatives are considered important candidate drugs for cancer treatment, with mechanisms including inhibiting cancer cell proliferation, inducing apoptosis, and anti-angiogenesis. Studies have shown their potential in clinical trials and practice.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Review Biochemistry & Molecular Biology

Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review

Ushna Laraib et al.

Summary: Tumor markers are important tools for predicting tumor behavior, and nanotechnology has enhanced sensitivity and selectivity in detecting these markers. However, obstacles such as low sample concentration still limit their application.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Article Plant Sciences

Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis

Xingkang Wu et al.

Summary: This study aimed to investigate the combined efficacy of Compound Kushen Injection (CKI)-derived combination strategies in p53-mutant CRC. The results showed that CKI combined with cisplatin (Cis) produced synergistic antitumor efficiency for p53-R273H/P309S mutant CRC cells. The combination of CKI and Cis reinforced cell death in a synergistic manner by inducing extrinsic apoptosis pathway.

JOURNAL OF ETHNOPHARMACOLOGY (2022)

Article Medicine, Research & Experimental

Protective effects of low-temperature plasma on cisplatin-induced nephrotoxicity

Peng Guo et al.

Summary: The application of LTP in medical treatment for cisplatin-induced nephrotoxicity has shown significant protective effects, improving clinical, physiological, and pathological indicators while maintaining the anticancer effect of cisplatin and demonstrating biological safety in normal rats.

LIFE SCIENCES (2022)

Article Medicine, Research & Experimental

Comparison of cisplatin-induced nephrotoxicity between single-dose and split-dose administration to rats

Keizo Fukushima et al.

Summary: This study compared the nephrotoxicity of a split dose of cisplatin (CDDP) with the conventional single dose in rats. It found that the split-dose group had significantly lower acute kidney injury (AKI) compared to the single-dose group, suggesting that a split-dose regimen could be an alternative strategy for CDDP-ineligible patients.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Materials Science, Multidisciplinary

Folate-conjugated thermal- and pH-responsive magnetic hydrogel as a drug delivery nano-system for smart chemo/hyperthermia therapy of solid tumors

Hossein Derakhshankhah et al.

Summary: A folate-conjugated pH- and thermal-sensitive magnetic hydrogel was developed as a smart drug delivery system for chemo/hyperthermia therapy of cancer cells. The hydrogel showed suitable drug loading and encapsulation efficiencies, and exhibited pH- and thermal-responsive drug release behavior under tumor conditions. The developed drug delivery system demonstrated synergistic cancer therapy by combining chemotherapy and hyperthermia approaches.

MATERIALS TODAY COMMUNICATIONS (2022)

Article Medicine, Research & Experimental

Danshensu attenuates cisplatin-induced nephrotoxicity through activation of Nrf2 pathway and inhibition of NF-kappa B

Chen Yu et al.

Summary: Danshensu has protective effects against cisplatin-induced nephrotoxicity by improving kidney damage, attenuating abnormal renal function indicators and oxidative stress, activating Nrf2/HO-1, and inhibiting the NF-kappa B pathway.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Medicine, Research & Experimental

Function of selected natural antidiabetic compounds with potential against cancer via modulation of the PI3K/AKT/mTOR cascade

Agustina Dwi Retno Nurcahyanti et al.

Summary: Natural secondary metabolites from medicinal plants with antidiabetic activities may hold promise for cancer therapy by modulating the PI3K/Akt/mTOR pathway. The study highlights a wide range of medicinal plants and bioactive compounds with antidiabetic properties that could be repurposed for potential anticancer activities.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Immunology

miR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-KB pathway

Shangting Han et al.

Summary: The study showed that miR-132-3p was significantly upregulated in cisplatin-induced AKI models, exacerbating AKI by negatively regulating SIRT1 and activating the NF-κB signaling pathway. Inhibition of miR-132-3p expression effectively suppressed apoptosis and inflammatory responses in cisplatin-stimulated cells.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Chemistry, Multidisciplinary

Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting

Mayank Handa et al.

Summary: Cancer is a leading cause of death worldwide, with current treatments considered suboptimal due to pathophysiological challenges. Nanotechnology has enabled the development of phytomedicine-based nanostructured delivery systems for more targeted cancer therapy.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Plant Sciences

Upregulation of UGT1A1 expression by ursolic acid and oleanolic acid via the inhibition of the PKC/NF-κB signaling pathway

Li Yuan et al.

Summary: The study reveals that PKC/NF-kappa B signaling downregulates UGT1A1 expression, while UA and OA promote the expression of UGT1A1 in HepG2 cells by inhibiting the PKC/NF-kappa B signaling pathway.

PHYTOMEDICINE (2021)

Article Oncology

Evolutions in the Management of Hepatocellular Carcinoma over Last 4 Decades: An Analysis from the 100 Most Influential Articles in the Field

Gang Xu et al.

Summary: By conducting bibliometric analysis on the 100 most influential articles over the past four decades, key contributions to the evolution and advancement of HCC management were highlighted. This analysis provides insight for clinicians and researchers on future directions in HCC management.

LIVER CANCER (2021)

Article Biochemistry & Molecular Biology

Pentraxin 3 acts as a functional effector of Akt/NF-κB signaling to modulate the progression and cisplatin-resistance in non-small cell lung cancer

Yanguang Li et al.

Summary: Pentraxin 3 (PTX3) has been shown to contribute to chemoresistance in cancer, and its silencing can inhibit proliferation, promote apoptosis, and enhance sensitivity to cisplatin (DDP) in non-small cell lung cancer (NSCLC) cells. Additionally, increased levels of PTX3 are associated with longer overall survival in lung adenocarcinoma and lung squamous cell carcinoma patients.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)

Article Medicine, General & Internal

Lanthanum Chloride Sensitizes Cisplatin Resistance of Ovarian Cancer Cells via PI3K/Akt Pathway

Shanyu Fang et al.

Summary: Lanthanum chloride (LaCl3) enhances the anticancer ability of cisplatin (DDP) in ovarian cancer cells by inducing more cell death and apoptosis caused by DDP, along with downregulation of Bcl-2 protein and inactivation of the PI3K/Akt pathway. LaCl3 may be a potential drug to modulate DDP resistance by attenuating DNA repair in ovarian cancer.

FRONTIERS IN MEDICINE (2021)

Article Medicine, Research & Experimental

Vincamine protects against cisplatin induced nephrotoxicity via activation of Nrf2/HO-1 and hindering TLR4/ IFN-γ/CD44 cells inflammatory cascade

Rehab M. El-Sayed et al.

Summary: The study revealed that vincamine has a protective effect against cisplatin-induced nephrotoxicity by reducing kidney damage through various mechanisms, including antioxidant, anti-inflammatory, and anti-apoptotic activities.

LIFE SCIENCES (2021)

Review Oncology

Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations

Kristen Renee McSweeney et al.

Summary: This article summarizes the characteristics of nephrotoxicity in cisplatin treatment, the pathophysiological mechanisms of kidney injury, and the current research on pharmacological treatment options to reduce AKI. Despite years of research, interventions, and clinical trials, there is still a lack of consistent pharmacological treatment options for cisplatin-induced acute kidney injury.

CANCERS (2021)

Article Biochemistry & Molecular Biology

Anticancer effects of oleanolic acid on human melanoma cells

Joong-Seok Woo et al.

Summary: OA treatment leads to induction of apoptosis in melanoma cells through increased apoptotic bodies and decreased expression of antiapoptotic proteins such as Bcl-2.

CHEMICO-BIOLOGICAL INTERACTIONS (2021)

Article Biochemistry & Molecular Biology

Nephrotoxicity induced by cisplatin is primarily due to the activation of the 5-hydroxytryptamine degradation system in proximal renal tubules

Jing Guan et al.

Summary: This study uncovered the relationship between ROS accumulation induced by cisplatin and 5-HT degradation, with a focus on the involvement of 5-HT2AR in proximal tubular epithelial cells. Inhibition of 5-HT2AR attenuated cisplatin-induced nephrotoxicity by regulating MAO-A, Tph1, and AADC expression levels.

CHEMICO-BIOLOGICAL INTERACTIONS (2021)

Review Oncology

Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients

Nalini Devarajan et al.

Summary: Cisplatin resistance in cancer treatment is often due to the hypoxic microenvironment in tumors, which leads to insensitivity. Understanding the molecular events behind hypoxia-induced cisplatin resistance is crucial in overcoming treatment failure. Various strategies have been developed to overcome cisplatin resistance in hypoxic tumors, but further clinical investigations and preclinical studies are needed to improve their pharmaceutical applications.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Article Pharmacology & Pharmacy

The combination of an innovative dry powder for inhalation and a standard cisplatin-based chemotherapy in view of therapeutic intensification against lung tumours

Selma Chraibi et al.

Summary: This study introduces a novel approach of therapeutic intensification by combining cisplatin dry powder for inhalation with intravenous cisplatin treatment for lung cancer. The dry powder showed good aerodynamic performance and demonstrated improved efficacy compared to intravenous cisplatin in mice models.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)

Article Immunology

Hydroxytyrosol protects against cisplatin-induced nephrotoxicity via attenuating CKLF1 mediated inflammation, and inhibiting oxidative stress and apoptosis

Chen Chen et al.

Summary: The study demonstrated that HT protected against CDDP-induced renal injury by inhibiting the CKLF1-mediated inflammatory pathway, as well as through anti-oxidative stress and anti-apoptotic effects.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Materials Science, Multidisciplinary

Prospects of an engineered tumor-targeted nanotheranostic platform based on NIR-responsive upconversion nanoparticles

Arjun Sabu et al.

Summary: Theranostics, including both therapeutic and diagnostic functions, is an innovative technology in personalized nanomedicine. Lanthanide-doped upconversion nanoparticles (UCNPs) have unique properties that allow them to be targeted using specific tumor-homing ligands, leading to effective treatment outcomes.

MATERIALS ADVANCES (2021)

Review Oncology

Nanomedicine-based strategies to target and modulate the tumor microenvironment

Barbara B. Mendes et al.

Summary: The interest in nanomedicine for cancer theranostics has grown significantly, but overcoming physiological barriers in the tumor microenvironment remains a challenge. Intrinsic tumor genetic/phenotypic variations and heterogeneity present unique challenges in translating nanotechnology-based systems into clinically reliable therapies.

TRENDS IN CANCER (2021)

Article Materials Science, Biomaterials

A pH-sensitive nanoagent self-assembled from a highly negatively-charged phthalocyanine with excellent biosafety for photothermal therapy

Bing-De Zheng et al.

Summary: The development of a highly efficient and biosafe photothermal agent NanoPc3 shows great potential for clinical applications in cancer treatment. Its pH-sensitive and highly negative surface potential properties allow for effective tumor treatment with little toxicity, establishing a new strategy for the design of tumor-targeted photothermal nanoagents with high biosafety.

JOURNAL OF MATERIALS CHEMISTRY B (2021)

Review Materials Science, Biomaterials

pH-Sensitive nanogels for drug delivery in cancer therapy

Zhen Li et al.

Summary: Nanogels are considered ideal drug carriers for cancer treatment due to their high stability, water content, and drug loading capacities. pH-sensitive nanogels, which utilize the lower pH value in tumor tissue, have shown potential for more precise drug delivery and release in cancer treatment.

BIOMATERIALS SCIENCE (2021)

Article Pharmacology & Pharmacy

Construction of redox-responsive tumor targeted cisplatin nano-delivery system for effective cancer chemotherapy

Yi-Yang Jia et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)

Article Neurosciences

TTDA inhibited apoptosis by regulating the p53-Bax/Bcl2 axis in glioma

Huan-Lan Bai et al.

EXPERIMENTAL NEUROLOGY (2020)

Article Chemistry, Multidisciplinary

Combined nanomedicines targeting colorectal cancer stem cells and cancer cells

Nikolaos Tsakiris et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Article Multidisciplinary Sciences

Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis

Junmei Yi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Materials Science, Multidisciplinary

Zein coated calcium carbonate nanoparticles for the targeted controlled release of model antibiotic and nutrient across the intestine

Meenakshi Gautam et al.

MATERIALS TODAY COMMUNICATIONS (2020)

Article Materials Science, Biomaterials

CaCO3 nanoparticles pH-sensitively induce blood coagulation as a potential strategy for starving tumor therapy

Huiru Li et al.

JOURNAL OF MATERIALS CHEMISTRY B (2020)

Review Pharmacology & Pharmacy

Mechanisms of drug release in pH-sensitive micelles for tumour targeted drug delivery system: A review

Zhe Wang et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Article Toxicology

Nrf2 activators as potential modulators of injury in human kidney cells

Amandla Atilano-Roque et al.

TOXICOLOGY REPORTS (2016)

Review Pharmacology & Pharmacy

Calcium carbonate nanoparticles as cancer drug delivery system

Solmaz Maleki Dizaj et al.

EXPERT OPINION ON DRUG DELIVERY (2015)

Article Biochemistry & Molecular Biology

Oleanolic acid co-administration alleviates ethanol-induced hepatic injury via Nrf-2 and ethanol-metabolizing modulating in rats

Jiangzheng Liu et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2014)

Article Chemistry, Multidisciplinary

Biodistribution, Tumor Uptake and Efficacy of 5-FU-Loaded Liposomes: Why Size Matters

Raphaelle Fanciullino et al.

PHARMACEUTICAL RESEARCH (2014)

Article Chemistry, Multidisciplinary

Nucleoside-Lipid-Based Nanoparticles for Cisplatin Delivery

Salim Khiati et al.

ACS NANO (2011)

Review Oncology

Pharmacokinetic variability of anticancer agents

SD Undevia et al.

NATURE REVIEWS CANCER (2005)